Ichiro Takata

4.3k total citations · 1 hit paper
50 papers, 3.4k citations indexed

About

Ichiro Takata is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ichiro Takata has authored 50 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Ichiro Takata's work include Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Ichiro Takata is often cited by papers focused on Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Ichiro Takata collaborates with scholars based in Japan, United States and United Kingdom. Ichiro Takata's co-authors include José Baselga, Danny Rischin, A. Feyereislova, Jean‐Yves Douillard, Richard Eek, Shinzoh Kudoh, Giuseppe Giaccone, Seiji Yano, Steven D. Averbuch and Takeshi Horai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ichiro Takata

48 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

2003 2.4k citations Masahiro Fukuoka, Seiji Yano et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ichiro Takata

Since Specialization

Citations

This map shows the geographic impact of Ichiro Takata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Takata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Takata more than expected).

Fields of papers citing papers by Ichiro Takata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Takata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Takata. The network helps show where Ichiro Takata may publish in the future.

Co-authorship network of co-authors of Ichiro Takata

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Takata. A scholar is included among the top collaborators of Ichiro Takata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Takata. Ichiro Takata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kidney Injury in Patient with Non-small-cell Lung Cancer Receiving Tepotinib 2024 ·Internal Medicine ·Naohiro Oda, (unknown), (unknown), Takehiko Tokura, Ichiro Takata	0
2	Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients 2024 ·International Journal of Molecular Sciences ·Mitsuru Tsuge, Eiki Ichihara, Kou Hasegawa, Kenichiro Kudo, Yasushi Tanimoto, Kazuhiro Nouso, Naohiro Oda, (unknown), Goro Kimura, (unknown), Ichiro Takata, Toshiharu Mitsuhashi, Akihiko Taniguchi, Kohei Tsukahara, Toshiyuki Aokage, Hideharu Hagiya, Shinichi Toyooka, Hirokazu Tsukahara, Yoshinobu Maeda	1
3	Atezolizumab-Induced Type 1 Diabetic Ketoacidosis in a Patient With Small Cell Lung Cancer and Pre-existing Type 2 Diabetes Mellitus 2024 ·Cureus ·(unknown), Naohiro Oda, (unknown), Ichiro Takata	1
4	Subdural hematoma due to skull base bone metastasis of epidermal growth factor receptor mutated non‐small cell lung cancer 2024 ·SHILAP Revista de lepidopterología ·(unknown), Naohiro Oda, Shigeru Daido, Ichiro Takata	1
5	A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection 2023 ·PLoS ONE ·Eiki Ichihara, Kou Hasegawa, Kenichiro Kudo, Yasushi Tanimoto, Kazuhiro Nouso, Naohiro Oda, (unknown), (unknown), Ichiro Takata, Hideharu Hagiya, Toshiharu Mitsuhashi, Akihiko Taniguchi, Shinichi Toyooka, Kohei Tsukahara, Toshiyuki Aokage, Hirokazu Tsukahara, Katsuyuki Kiura, Yoshinobu Maeda	1
6	Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran 2022 ·Respiratory Medicine Case Reports ·Naohiro Oda, (unknown), Ichiro Takata, Mikio Kataoka	3
7	Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir 2021 ·SHILAP Revista de lepidopterología ·Naohiro Oda, (unknown), (unknown), (unknown), (unknown), (unknown), Toshiaki Okada, Ichiro Takata	4
8	Exacerbation of pulmonary cryptococcosis associated with enhancement of Th2 response in the postpartum period 2021 ·Journal of Infection and Chemotherapy ·(unknown), Naohiro Oda, Yuka Gion, (unknown), (unknown), Ichiro Takata, Akihiko Taniguchi, Yasuharu Sato, Nobuaki Miyahara	2
9	Legionella longbeachae pneumonia: A case report and literature review in Japan 2021 ·Journal of Infection and Chemotherapy ·Naohiro Oda, (unknown), (unknown), Ichiro Takata	1
10	Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group 2012 ·Lung Cancer ·Shigeki Umemura, Kazuya Tsubouchi, Hiroshige Yoshioka, Katsuyuki Hotta, Nagio Takigawa, Keiichi Fujiwara, (unknown), Yoshihiko Segawa, Noboru Hamada, Ichiro Takata, Hiromichi Yamane, Haruhito Kamei, Katsuyuki Kiura, Mitsune Tanimoto	91
11	Triple Combination Chemotherapy with Cisplatin, Docetaxel, and Irinotecan for Advanced Non-small Cell Lung Cancer: A Phase I/II Trial 2007 ·Journal of Thoracic Oncology ·Katsuyuki Kiura, Nagio Takigawa, Yoshihiko Segawa, Masahiro Tabata, Takuo Shibayama, Kenichi Gemba, Akihiro Bessho, Nobukazu Fujimoto, Ichiro Takata, Katsuyuki Hotta, Keiichi Fujiwara, Yoshiyuki Tokuda, Shoichi Kuyama, Tetsu Shinkai, Hiroshi Ueoka, Mitsune Tanimoto	4
12	Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer breakdown → 2003 ·Journal of Clinical Oncology ·Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, Tomohide Tamura, Kazuhiko Nakagawa, Jean‐Yves Douillard, Yutaka Nishiwaki, Johan Vansteenkiste, Shinzoh Kudoh, Danny Rischin, Richard Eek, Takeshi Horai, Kazumasa Noda, Ichiro Takata, Egbert F. Smit, Steven D. Averbuch, (unknown), A. Feyereislova, (unknown), José Baselga	2392
13	Hypercalcemia–leukocytosis syndrome associated with lung cancer 2003 ·Lung Cancer ·Akio Hiraki, Hiroshi Ueoka, Ichiro Takata, Kenichi Gemba, Akihiro Bessho, Yoshihiko Segawa, Katsuyuki Kiura, Kenji Eguchi, Toshiyuki Yoneda, Mitsune Tanimoto, Mine Harada	34
14	Small Bowel Metastasis From Large Cell Carcinoma of the Lung: Report of Two Cases. 2001 ·Haigan ·Ichiro Takata, Yoshihiko Segawa, Masahiro Tabata, Katsuyuki Kiura, Hiroshi Ueoka, Kenji Eguchi	1
15	Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer 2000 ·Lung Cancer ·Nobukazu Fujimoto, Akio Hiraki, Hiroshi Ueoka, Katsuyuki Kiura, Akihiro Bessho, Ichiro Takata, Yasushi Hiramatsu, Kazuma Ikeda, (unknown)	7
16	Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer 2000 ·Cancer Chemotherapy and Pharmacology ·Nagio Takigawa, Yoshihiko Segawa, Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Takuo Shibayama, Ichiro Takata, (unknown), (unknown), Mine Harada	11
17	Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation 1997 ·Lung Cancer ·Yoshihiko Segawa, Nagio Takigawa, (unknown), (unknown), Ichiro Takata, Nobukazu Fujimoto, Kenji Jinno	11
18	Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features 1997 ·Lung Cancer ·Nagio Takigawa, Yoshihiko Segawa, Koichi Mandai, Ichiro Takata, Nobukazu Fujimoto	9
19	Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation 1996 ·Lung Cancer ·Nagio Takigawa, (unknown), (unknown), (unknown), Ichiro Takata, Masaaki Kataoka, Masafumi Fujii	71
20	Statistics of herpes zoter in a city with a population of 200,000. 1990 ·The Nishinihon Journal of Dermatology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoko Mori, Junko Nagai, Yoko Hara, Ichiro Takata, Tomohisa Yamamoto, (unknown), Midori Yamamoto, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact